They reported hsa-miR-199a-5p to be decreased in HCC tissue, resulting in an increased expression of XBP1 and cyclin D, impacting the cell cycle regulation, suggesting that hsa-miR-199a-5p has an antitumor effect. This evidence concerns the gene XBP1 and hepatocellular carcinoma.